Keywords: Africa, Ciprofloxacin, Prices, Bayer, Antibiotics
Africa pays more than Asia and Europe for key antibiotic ciprofloxacin
Article | 14 January 2010
A global price survey has revealed that the price of a commonly used antibiotic ciprofloxacin is beyond the reach of many people in Africa because of its high cost. Health Action International (HAI) conducted the spot check on November 30, 2009, to ascertain the full price which a patient would pay for ciprofloxacin, in the nearest private retail pharmacy.
C Enjoying this article? To continue reading you need to login, take a FREE trial or subscribe.
FREE unlimited, no obligation access to The Pharma Letter website for 30 days, normally worth £60!
Sign up in less than 60 seconds...no payment needed
Want to read the full article?
Take a 30 day FREE Trial worth £60
Take a no obligations 30 day trial.
Only one trial per user. Find out more details
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Pfizer acts to stop Mylan marketing generic Chantix; Allergan in $600 million settlement over Botox marketing practices
- PDL BioPharma sues Roche’s Genentech over royalties
- Novartis/NIH-sponsored research yields promising malaria drug candidate
- Indian’s Ranbaxy inaugurates new $30 million drug manufacturing facility in South Africa
- Seattle Genetics gets milestone as Astellas unit moves cancer drug into Ph I
